The role of Probiotics in allergic diseases

Allergy, Asthma and Clinical Immunology

Volumn 5, Issue 1, 2009, Pages

  Michail, Sonia ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957969740     PISSN: 17101484     EISSN: 17101492     Source Type: Journal    
DOI: 10.1186/1710-1492-5-5     Document Type: Review

References (63)

1. Warner JO, et al. Allergy practice worldwide. a report by the World Allergy Organization Specialty and Training Council. Int Arch Allergy Immunol 2006, 139(2):166-74. 10.1159/000090502, 16388197.
2. Lovasi GS, et al. Children living in areas with more street trees have lower prevalence of asthma. J Epidemiol Community Health 2008, 62(7):647-9. 10.1136/jech.2007.071894, 18450765.
3. Romagnani S. Thiand Th2 in human diseases. Clin Immunol Immunopathol 1996, 80(3 Pt 1):225-35. 10.1006/clin.1996.0118, 8811042.
4. Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the 'hygiene hypothesis'. too clean to be true?. Br J Dermatol 2005, 152(2):202-16. 10.1111/j.1365-2133.2004.06436.x, 15727630.
5. Ouwehand AC. Antiallergic effects of probiotics. J Nutr 2007, 137(3 Suppl 2):794S-7S.
6. Ogden NS, Bielory L. Probiotics. a complementary approach in the treatment and prevention of pediatric atopic disease. Curr Opin Allergy Clin Immunol 2005, 5(2):179-84. 10.1097/01.all.0000162312.64308.fc, 15764910.
7. Kirjavainen PV, et al. Aberrant composition of gut microbiota of allergic infants. a target of bifidobacterial therapy at weaning?. Gut 2002, 51(1):51-5. 10.1136/gut.51.1.51, 1773282, 12077091.
8. Kirjavainen PV, et al. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol 2001, 32(1):1-7. 10.1111/j.1574-695X.2001.tb00526.x, 11750215.
9. Bjorksten B. The gastrointestinal flora and the skin--Is there a link?. Pediatr Allergy Immunol 2001, 12(Suppi 14):51-5. 10.1034/j.1399-3038.2001.121412.x, 11380900.
10. Sepp E, et al. Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy 2005, 35(9):1141-6. 10.1111/j.1365-2222.2005.02315.x, 16164439.
11. Voor T, et al. Atopic sensitization and atopic dermatitis in Estonian and Swedish infants. Clin Exp Allergy 2005, 35(2):153-9. 10.1111/j.1365-2222.2005.02157.x, 15725185.
12. Bjorksten B, et al. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2005, 108(4):16-20.
13. Watanabe S, et al. Differences infecalmicroflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 2005, 111(3):587-91.
14. Kirjavainen PV, Gibson GR. Healthy gut microflora and allergy. factors influencing development of the microbiota. Ann Med 1999, 31(4):288-92. 10.3109/07853899908995892, 10480760.
15. Kalliomaki M, Isolauri E. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol 2003, 3(1):15-20. 10.1097/00130832-200302000-00003, 12582309.
16. He F, et al. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 2001, 30(1):43-7. 10.1111/j.1574-695X.2001.tb01548.x, 11172990.
17. Ouwehand A, Isolauri E, Salminen S. The role of the intestinal microflora for the development of the immune system in early childhood. Eur J Nutr 2002, 41(Suppi 1):I32-7.
18. Penders J, et al. Molecular finger printing of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin Exp Allergy 2006, 36(12):1602-8. 10.1111/j.1365-2222.2006.02599.x, 17177684.
19. Adlerberth I, et al. Gut microbiota and development of atopic eczema in 3 European birth cohorts. J Allergy Clin Immunol 2007, 120(2):343-50. 10.1016/j.jaci.2007.05.018, 17604093.
20. (WHO), FaAOFotUNaWHO Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. Accessed on December 7, 2006, (WHO), FaAOFotUNaWHO.
21. Winkler P, et al. Molecular and cellular basis of microflora-host interactions. J Nutr 2007, 137(3 Suppl 2):756S-72S.
22. Flinterman AE, et al. Probiotics have a different immunomodulatory potential in vitro versus ex vivo upon oral administration in children with food allergy. Int Arch Allergy Immunol 2007, 143(3):237-44. 10.1159/000099467, 17290150.
23. Prescott SL, et al. Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clin Exp Allergy 2005, 35(12):1557-64.
24. Taylor AL, et al. Effects of probiotic supplementation for the first 6 months of life on allergen-and vaccine-specific immune responses. Clin Exp Allergy 2006, 36(10):1227-35. 10.1111/j.1365-2222.2006.02553.x, 17014429.
25. Enomoto T, Shimizu K, Shimazu S. [Suppression of allergy development by habitual intake offermented milkfoods, evidence from an epidemiological study]. Arerugi 2006, 55(11):1394-9.
26. Kalliomaki M, et al. Probiotics in primary prevention of atopic disease. a randomised placebo-controlled trial. Lancet 2001, 357(9262):1076-9. 10.1016/S0140-6736(00)04259-8, 11297958.
27. Kalliomaki M, et al. Probiotics and prevention of atopic disease. 4-yearfollow-up of a randomised placebo-controlled trial. Lancet 2003, 361(9372):1869-71. 10.1016/S0140-6736(03)13490-3, 12788576.
28. Kalliomaki M, et al. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007, 119(4):1019-21. 10.1016/j.jaci.2006.12.608, 17289135.
29. Lodinova-Zadnikova R, et al. [Influence of oral colonization with probiotic E. coli strain after birth on frequency of recurrent infections, allergy and development of some immunologic parameters. Long-term studies]. Ceska Gynekol 2004, 69(Suppi 1):91-7.
30. Lodinova-Zadnikova R, Cukrowska B, Tlaskalova-Hogenova H. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol 2003, 131(3):209-11. 10.1159/000071488, 12876412.
31. Abrahamsson TR, et al. Probiotics in prevention of IgE-associated eczema. a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007, 119(5):1174-80. 10.1016/j.jaci.2007.01.007, 17349686.
32. Kukkonen K, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases. a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007, 119(1):192-8. 10.1016/j.jaci.2006.09.009, 17208601.
33. Taylor AL, et al. FOXP3 mRNA expression at 6 months of age is higher in infants who develop atopic dermatitis, but is not affected by giving probiotics from birth. Pediatr Allergy Immunol 2007, 18(1):10-9. 10.1111/j.1399-3038.2006.00483.x, 17295794.
34. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children. a randomized controlled trial. J Allergy Clin Immunol 2007, 119(1):184-91. 10.1016/j.jaci.2006.08.036, 17208600.
35. Moro G, et al. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 2006, 91(10):814-9. 10.1136/adc.2006.098251, 2066015, 16873437.
36. Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007, (4):CD006475.
37. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997, 99(2):179-85. 10.1016/S0091-6749(97)70093-9, 9042042.
38. Isolauri E, et al. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000, 30(11):1604-10. 10.1046/j.1365-2222.2000.00943.x, 11069570.
39. Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease. underscoring the importance of viability. J Pediatr Gastroenterol Nutr 2003, 36(2):223-7. 10.1097/00005176-200302000-00012, 12548058.
40. Passeron T, et al. Prebiotics and synbiotics. two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy 2006, 61(4):431-7. 10.1111/j.1398-9995.2005.00956.x, 16512804.
41. Viljanen M, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants. a double-blind placebo-controlled trial. Allergy 2005, 60(4):494-500. 10.1111/j.1398-9995.2004.00514.x, 15727582.
42. Viljanen M, et al. Probiotic effects onfaecal inflammatory markers and onfaecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol 2005, 16(1):65-71. 10.1111/j.1399-3038.2005.00224.x, 15693914.
43. Rosenfeldt V, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003, 111(2):389-95. 10.1067/mai.2003.389, 12589361.
44. Sistek D, et al. Is the effect of probiotics on atopic dermatitis confined to food sensitized children?. Clin Exp Allergy 2006, 36(5):629-33. 10.1111/j.1365-2222.2006.02485.x, 16650048.
45. Brouwer ML, et al. No effects of probiotics on atopic dermatitis in infancy. a randomized placebo-controlled trial. Clin Exp Allergy 2006, 36(7):899-906. 10.1111/j.1365-2222.2006.02513.x, 16839405.
46. Folster-Holst R, et al. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol 2006, 155(6):1256-61. 10.1111/j.1365-2133.2006.07558.x, 17107398.
47. Weston S, et al. Effects of probiotics on atopic dermatitis. a randomised controlled trial. Arch Dis Child 2005, 90(9):892-7. 10.1136/adc.2004.060673, 1720555, 15863468.
48. Passeron T, Lacour J. Effects of Probiotics on Atopic Dermatitis. Arch Dis Child 2005, 20(4):171-176.
49. Gruber C, et al. Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy 2007, 62(11):1270-6. 10.1111/j.1398-9995.2007.01543.x, 17919141.
50. Michail S, Onady G, Stolfi A, Johnson T. Efficacy of probiotics in treatment ofpediatric atopic dermatitis a meta-analysis of randomized, controlled trials. 2008, 101(5):508-16.
51. Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008, 121(1):116-121. 10.1016/j.jaci.2007.10.043, 18206506.
52. Giovannini M, et al. A randomized prospective double blind controlled trial on effects of longterm consumption offermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr Res 2007, 62(2):215-20. 10.1203/PDR.0b013e3180a76d94, 17597643.
53. Wheeler JG, et al. Immune and clinical impact of Lactobacillus acidophilus on asthma. Ann Allergy Asthma Immunol 1997, 79(3):229-33.
54. Wang MF, et al. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatr Allergy Immunol 2004, 15(2):152-8. 10.1111/j.1399-3038.2004.00156.x, 15059192.
55. Xiao JZ, et al. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial. Clin Exp Allergy 2006, 36(11):1425-35. 10.1111/j.1365-2222.2006.02575.x, 17083353.
56. Xiao JZ, et al. Effect of probiotic Bifidobacterium longum BB536 [corrected] in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo-controlled trial. J Investig Allergol Clin Immunol 2006, 16(2):86-93.
57. Morita H, et al. Preliminary human study for possible alteration of serum immunoglobulin E production in perennial allergic rhinitis with fermented milk prepared with Lactobacillus gasseri TMCO356. Microbiol Immunol 2006, 50(9):701-6.
58. Xiao JZ, et al. Changes in plasma TARC levels during Japanese cedar pollen season and relationships with symptom development. Int Arch Allergy Immunol 2007, 144(2):123-7. 10.1159/000103223, 17536220.
59. Xiao JZ, et al. Clinical efficacy of probiotic Bifidobacterium longum for the treatment of symptoms of Japanese cedar pollen allergy in subjects evaluated in an environmental exposure unit. Allergol Tnt 2007, 56(1):67-75.
60. Tshida Y, et al. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study. J Dairy Sci 2005, 88(2):527-33.
61. Peng GC, Hsu CH. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr Allergy Tmmunol 2005, 16(5):433-8.
62. Helin T, Haahtela S, Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 2002, 57(3):243-6. 10.1034/j.1398-9995.2002.1s3299.x, 11906339.
63. Tamura M, et al. Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: randomized double-blind, placebo-controlled clinical trial. Tnt Arch Allergy Tmmunol 2007, 143(1):75-82.